Change in plasma H2S level and therapeutic effect of H 2S supplementation in tubulointerstitial fibrosis among rats with unilateral ureteral obstruction

Chinese Journal of Contemporary Pediatrics

Volumn 15, Issue 10, 2013, Pages 903-908

  Zhao, De An ^a   Liu, Jun ^a   Huang, Qian ^a   Han, Zi Ming ^a  

^a XINXIANG MEDICAL UNIVERSITY   (China)

Author keywords

Cystathionine beta synthase; Cystathionine gamma lyase; Hydrogen sulfide; Rat; Tubulointerstitial fibrosis; Ureteral obstruction

Indexed keywords

CYSTATHIONINE BETA SYNTHASE; CYSTATHIONINE GAMMA LYASE; HYDROGEN SULFIDE; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG MEGADOSE; IMMUNOHISTOCHEMISTRY; KIDNEY INJURY; LOW DRUG DOSE; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; RENAL TUBULOINTERSTITIAL FIBROSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; URETER OBSTRUCTION; ANIMAL; BLOOD; DIET SUPPLEMENTATION; FIBROSIS; GENETICS; KIDNEY TUBULE; PATHOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; CYSTATHIONINE BETA-SYNTHASE; CYSTATHIONINE GAMMA-LYASE; DIETARY SUPPLEMENTS; FIBROSIS; HYDROGEN SULFIDE; KIDNEY TUBULES; MALE; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; URETERAL OBSTRUCTION;

EID: 84887926729     PISSN: 10088830     EISSN: None     Source Type: Journal    
DOI: 10.7499/j.issn.1008-8830.2013.10.020     Document Type: Article

References (10)

1. Stipanuk MH, Beck PW. Characterization of the enzymic capacity for cysteine desulphhydration in liver and kidney of the rat[J]. Biochem J, 1982, 206(2): 267-277.
2. House JD, Brosnan ME, Brosnan JT. Characterization of homocysteine metabolism in the rat kidney[J]. Biochem J, 1997, 328(Pt1): 287-292.
3. Bascands JL, Schanstra JP. Obstructive nephropathy: Insights from genetically engineered animals[J]. Kidney Int, 2005, 68(3): 925-937.
4. Nishida M, Hamaoka K. Macrophage phenotype and renal fibrosis in obstructive nephropathy[J]. Nephron Exp Nephrol, 2008, 110(1): e31-e36.
5. Cregger M, Berger AJ, Rimm DL. Immunohistochemistry and quantitative analysis of protein expression[J]. Arch Pathol Lab Med, 2006, 130(7): 1026-1030.
6. Nanqaku M. Mechanisms of tubulointerstitial injury in the kindey:final common pathways to end-stage renal failure[J]. Intern Med, 2004, 43(1): 9-17.
7. Tripatara P, Patel NS, Collino M, Gallicchio M, Kieswich J, Castiglia S, et al. Generation of endogenous hydrogen sulfide by cystathionine gamma-lyase limits renal ischemia/reperfusion injury and dysfunction[J]. Lab Invest, 2008, 88(10): 1038-1048.
8. Della Coletta Francescato H, Cunha FQ, Costa RS, Barbosa Junior F, Boim MA, Arnoni CP, et al. Inhibition of hydrogen sulphide formation reduces cisplatin-induced renal damage[J]. Nephrol Dial Transplant, 2011, 26(2): 479-488.
9. Perna AF, Luciano MG, Ingrosso D, Raiola I, Pulzella P, Sepe I, et al. Hydrogen sulfide, the third gaseous signaling molecule with cardiovascular properties, is decreased in hemodialysis patients[J]. J Ren Nutr, 2010, 20(5): S11-S14.
10. Xia M, Chen L, Muh RW, Li PL, Li N. Production and actions of hydrogen sulfide, a novel gaseous bioactive substance, in the kidneys[J]. J Pharmacol Exp Ther, 2009, 329(3): 1056-1062.